pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 0 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07483073: A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Colitis, Ulcerative, Crohn Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07147569: TAMBE Japan Post-Marketing Surveillance

Sponsor: W.L.Gore & Associates. Phase: . Conditions: Thoracoabdominal Aortic Aneurysm, Pararenal Aortic Aneurysm

full page →ctgov ↗
›RECRUITINGphase readoutNCT07007169: Mediterranean Diet and Inequality in Early Breast Cancer

Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark. Phase: PHASE2. Conditions: Early Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07352683: Open TAP-block in Pediatric Abdominal Surgery

Sponsor: Uppsala University. Phase: NA. Conditions: Pain Management After Surgery

full page →ctgov ↗
›SUSPENDEDphase readoutNCT03580083: RGX-111 Gene Therapy in Patients With MPS I

Sponsor: REGENXBIO Inc.. Phase: PHASE1. Conditions: Mucopolysaccharidosis Type I (MPS I), Hurler Syndrome, Hurler-Scheie Syndrome

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04106466: DBS for TRD With the Medtronic Summit RC+S

Sponsor: Helen Mayberg, MD. Phase: NA. Conditions: Major Depressive Disorder, Treatment Resistant Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT05492422: Central Executive Training and Parent Training for ADHD

Sponsor: Florida State University. Phase: NA. Conditions: ADHD

full page →ctgov ↗
›TERMINATEDphase readoutNCT04370522: Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer

Sponsor: Spanish Breast Cancer Research Group. Phase: . Conditions: Metastatic Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03920722: Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: PHASE3. Conditions: Microscopic Polyangiitis (MPA)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07502729: Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive Bleeding

Sponsor: Shanghai Zhongshan Hospital. Phase: . Conditions: Portal Hypertension, Gastroesophageal Varices Hemorrhage, Gastric Varices, Esophageal Varices

full page →ctgov ↗
›AVAILABLEphase readoutNCT03123029: Expanded Access to Venetoclax

Sponsor: AbbVie. Phase: . Conditions: Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin's Lymphoma, Acute Lymphoblastic Leukemia (ALL), Amyloidosis, Plasma Cell Leukemia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07411924: Mastication, Cognition, and Nutritional Status in Multiple Sclerosis

Sponsor: Ondokuz Mayıs University. Phase: . Conditions: Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06564623: Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE1. Conditions: Biliary Tract Cancers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07524023: Emotional-distress-based Integrated Care Programme in Patients With Stable COPD

Sponsor: University of Zurich. Phase: NA. Conditions: COPD, COPD (Chronic Obstructive Pulmonary Disease)

full page →ctgov ↗
›COMPLETEDphase readoutNCT04702880: A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

Sponsor: Bristol-Myers Squibb. Phase: PHASE2. Conditions: Extensive-stage Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT00001979: Immune System Related Kidney Disease

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Phase: . Conditions: Kidney Disease, Nephrotic Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT06681246: The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment

Sponsor: Weizmann Institute of Science. Phase: NA. Conditions: Obesity, Weight Loss

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00582296: Multi-Organ Screening Recommendations in Patients With Lynch Syndrome

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Lynch Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT05362903: A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Hypercholesterolemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07413042: A Phase I Study to Evaluate the Safety and Preliminary Efficacy of [225Ac]Ac-DOTATATE Injection Combined With Tislelizumab in the Maintenance Treatment Period for Patients of Extensive-stage Small Cell Lung Cancer (ES-SCLC) With Somatostatin Receptors (SSTR)+ as First-line Treatment

Sponsor: Peking University Cancer Hospital & Institute. Phase: PHASE1. Conditions: SCLC, Extensive Stage

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05932342: Improving Cognition of Older Adults in Community Housing

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Aging, Mental Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07218770: A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE1. Conditions: Active Noninfectious Uveitis Affecting the Posterior Segment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07469969: Transcutaneous Auricular Vagus Nerve Stimulation Combined With Tailor-Made Notched Music Training Therapy for Chronic Subjective Tinnitus

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: NA. Conditions: Chronic Subjective Tinnitus

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05979441: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Sponsor: argenx. Phase: PHASE3. Conditions: Myositis, Active Idiopathic Inflammatory Myopathy, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT05302583: Aromatherapy Inhaler Use for HSCT Distress

Sponsor: Stanford University. Phase: NA. Conditions: Cancer Distress, Cancer Coping, Hematopoetic Stem Cell Transplant, Aromatherapy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03648905: Clinical Laboratory Evaluation of Chronic Autonomic Failure

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Parkinson's Disease, Multiple System Atrophy, Autonomic Failure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06642805: Bilio-pancreatic Complications of Congenital Duodenal Obstructions

Sponsor: University Hospital, Angers. Phase: . Conditions: Duodenal Obstruction

full page →ctgov ↗
›RECRUITINGphase readoutNCT06752356: A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Sponsor: Kedrion S.p.A.. Phase: PHASE3. Conditions: Chronic Inflammatory Demyelinating Polyneuropathy

full page →ctgov ↗
›COMPLETEDphase readoutNCT06265051: Tirofiban After Successful MT Recanalization in AIS

Sponsor: Xiang Luo. Phase: PHASE2. Conditions: Acute Ischemic Stroke, Vessel Occlusion

full page →ctgov ↗
›RECRUITINGphase readoutNCT06553131: Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison

Sponsor: Loma Linda University. Phase: . Conditions: Neuromuscular Blockade

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07539129: Investigating the Efficacy of Oral Probiotics Versus Placebo in Pakistani Patients With Moderate Acne on Acne Lesion Count and Systemic Inflammation

Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Acne Vulgaris

full page →ctgov ↗
›TERMINATEDphase readoutNCT04644029: Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: HIV-I, Human Immunodeficiency Virus Type 1, Prophylaxis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07320053: Effect of Longitudinal Care in Primary Health Care: An Analysis From the Patient's Perspective

Sponsor: IBS Granada. Phase: . Conditions: Age 65 and Older, Polypharmacy, Cronic Lung Disease, Mental Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06854653: A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

Sponsor: Prescient Therapeutics, Ltd.. Phase: PHASE2. Conditions: CTCL

full page →ctgov ↗
›RECRUITINGphase readoutNCT07227337: Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study

Sponsor: Johns Hopkins University. Phase: NA. Conditions: Post Traumatic Stress Disorder, Depression, Violence

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04021537: Non-invasive Nerve Stimulation and Sleep

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: PTSD

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07614672: Effects Of Instrument Assisted Soft Tissue Mobilization as Compared With Manual Longitudinal Friction Massage in Individuals With Plantar Fasciitis.

Sponsor: Ibadat International University, Islamabad. Phase: NA. Conditions: Plantar Fasciitis of Both Feet

full page →ctgov ↗
›RECRUITINGphase readoutNCT07052253: A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.

Sponsor: Akeso. Phase: PHASE2. Conditions: Hepatocellular Carcinoma (HCC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07310953: Clinical Utility of the Numerical Verbal Scale (NVS) and the Pain and Functional Activity Scale (PFAS) in the Management of Rescue Analgesia in Acute Postoperative Pain. Randomized Study.

Sponsor: Fundacin Biomedica Galicia Sur. Phase: NA. Conditions: Analgesia, Post Operative Pain, Acute Pain, Functional; Anesthesia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06135753: Psychosomatic Intervention in Fibromyalgia.

Sponsor: University of Florence. Phase: NA. Conditions: Fibromyalgia

full page →ctgov ↗
›RECRUITINGphase readoutNCT03384537: Antimicrobial Effect of Tropolone Containing Versus Tropolone Free Mouthwash

Sponsor: Cairo University. Phase: EARLY_PHASE1. Conditions: Dental Diseases

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07404345: Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)

Sponsor: Hospital Civil de Guadalajara. Phase: PHASE4. Conditions: Hemodialysis Access Failure, Kidney Disease, End-Stage, Hemodialysis Catheter

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07536139: COMPARATIVE EFFICACY OF ELECTROMAGNETIC FIELD THERAPY AND TIBIAL NERVE STIMULATION IN URGE URINARY INCONTINENCE

Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: NA. Conditions: Urge Urinary Incontinence

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07462039: Effect of Virtual Reality on Pain and Anxiety During Pap Smear Testing

Sponsor: Eastern Mediterranean University. Phase: NA. Conditions: Nurse's Role, Pain Management, Cervical Cancer Screening, Anxiety

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07555639: An Integrated Genomic Approach to Assess Genetic Risk and Drug Sensitivity

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: NA. Conditions: Colon Cancer, Breast Cancer, Ovarian Cancer, Genetic Risk Factors

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06737432: Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.

Sponsor: The University of Texas Medical Branch, Galveston. Phase: NA. Conditions: Ventilation, ARDS, Respiratory Failure, Mechanical Ventilation, Ventilator-induced Lung Injury (VILI), Quality Improvement, Ventilator Associated Events

full page →ctgov ↗
›COMPLETEDphase readoutNCT05499832: Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: PHASE3. Conditions: Ischemic Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT07205198: A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

Sponsor: Shanghai Institute Of Biological Products. Phase: PHASE1. Conditions: Advanced Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT06321198: A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

Sponsor: Anhui Provincial Hospital. Phase: NA. Conditions: Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06264063: Study of Behavioral Dysfunctions and Related Neuronal Correlates in Patients With Dystonia

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo. Phase: NA. Conditions: Dystonia, Neurologic Disorder, NEUROSCIENCE

full page →ctgov ↗
← prev
page 96 of 161
next →